Latest News
Higher MACCE Risk in PCI With Persistent High RIR and Low Baseline LDL
Pulmonary Vasodilators Reduce Mortality in Pediatric Pulmonary Hypertension
Dabigatran Not Superior to Aspirin for Preventing Recurrent Stroke
Aclidinium Delays COPD Event Onset, Does Not Increase MACE Risk
Increased Risk for Adverse Outcomes With Mild Pulmonary Hypertension in HFpEF
Updated NLA Guidance Identifies Patients in Which PCSK9i Use Provides Reasonable Value
Habitual Glucosamine Use Linked to Reduced Risk for CVD Events
Bipolar Disorder in Siblings May Increase Risk for Cardiometabolic Disease
First Anticoagulant Approved to Treat Symptomatic VTE in Pediatric Patients
Effect of Nonobstructive Coronary Artery Disease on Heart Failure Outcomes
Effects of Staged Balloon Pulmonary Angioplasty for CTEPH on Renal Function
Afib Diagnosed During Critical Care Linked to Higher Long-Term Stroke Risk
Alteplase Seems Beneficial at 4.5 to 9.0 Hours After Stroke
Patients Find Note Reading Important for Health Management
Latest Features
Cardiovascular Risk in Pediatric Obstructive Sleep Apnea: What Do We Know?
A panel of 4 clinicians with experience in pediatric pulmonology discuss current research findings and gaps in studies of pediatric obstructive sleep apnea, particularly regarding cardiovascular risk.
Drug-Induced Pulmonary Arterial Hypertension: A More Complicated Prognosis
The prognosis for patients with idiopathic pulmonary arterial hypertension is substantially worse than for patients with idiopathic PAH.
Excipients in Medications May Trigger Adverse Reactions in Some Patients
A team of investigators from both Brigham and Women’s Hospital and the Massachusetts Institute of Technology analyzed data on thousands of inactive ingredients in approved medications to further characterize them and enhance our knowledge of their safety.
